English | Español

Celgene Corporation
Karen Kidd | Oct 23, 2018

Think tank founder recommends standard patents over intellectual property rights to cut drug prices
Carrice Quinnie | Jun 2, 2017

Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis
LocalLabs News Service | Apr 10, 2017

Oral medication reduced psoriasis symptoms, study says
Gene Johnson | Mar 10, 2017

FDA accepts Celgene Corp.'s application for leukemia treatment drug
Amanda Rupp | Aug 19, 2016

Torres, Celgene partner for psoriasis campaign
Amanda Rupp | Jun 1, 2016

World MS Day research to increase independence of MS patients
Amanda Rupp | May 16, 2016

Acute myeloid leukemia persists as major health problem
Amanda Rupp | Apr 14, 2016

WHO calls for better accessibility to psoriasis treatments

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+ Pharmaceuticals
Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program
+ Pharmaceuticals
Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’